Home › Crohn's Disease › Illinois › Arlington Heights
Crohn's Disease clinical trials in Arlington Heights, IL
3 studies for Crohn's Disease are looking for participants at sites in and around Arlington Heights (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of Advanced Therapies for the Treatment of Adult Participants With Moderately to Severely Active Crohn's Disease or Ulcerative Colitis
RecruitingPhase 2
- Midwest Digestive Health & Nutrition /ID# 285250, Des Plaines · 6 mi away
A Study of Vedolizumab in Adults With Ulcerative Colitis (UC) or Crohn's Disease (CD) in the Community Setting
RecruitingPhase 4
- Gastroenterology and Internal Medicine Specialists, SC, Lake Barrington · 12 mi away
An Induction Study to Investigate the Efficacy and Safety of Duvakitug in Participants With Moderately to Severely Active Crohn's Disease
RecruitingPhase 3
- Midwest Digestive Health and Nutrition-Site Number: 8400136, Des Plaines · 6 mi away
About Crohn's Disease
Crohn's Disease can cause inflammation in any area from the mouth to the anus. Read about medicines, surgery or dietary management to treat symptoms.
More about Crohn's Disease on MedlinePlus
Crohn's Disease trials in other cities
- New York City, NY35 studies
- Cleveland, OH19 studies
- St. Louis, MO19 studies
- Boston, MA19 studies
- Miami, FL19 studies
- Orlando, FL17 studies
- Houston, TX17 studies
- Atlanta, GA17 studies
- Tyler, TX16 studies
- San Diego, CA15 studies
- San Antonio, TX15 studies
- Los Angeles, CA15 studies
Other studies in Arlington Heights
- Non-Small Cell Lung Cancer12 studies
- Colorectal Cancer12 studies
- Lung Cancer9 studies
- Heart Failure7 studies
- Breast Cancer7 studies
- Metastatic Cancer6 studies
- Ulcerative Colitis6 studies
- Colon Cancer6 studies
- Ovarian Cancer5 studies
- Obesity4 studies
- Overweight4 studies
- Cancer (all types)3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.